iBankCoin
Home / Dr. Fly (page 134)

Dr. Fly

18 years in Wall Street, left after finding out it was all horseshit. Founder/ Master and Commander: iBankCoin, finance news and commentary from the future.

Flash: Amazon.com sees Q2 operating income of $95-245 vs $356 mln consensus (32% y/y consensus growth)

Amazon.com reports Q1 (Mar) results, beats on revs; guides Q2 revs in-line  (182.30 -3.12)
Reports Q1 (Mar) earnings of $0.44 per share, may not be comparable to the Thomson Reuters consensus of $0.60; revenues rose 38.3% year/year to $9.86 bln vs the $9.53 bln consensus. Co issues in-line guidance for Q2, sees Q2 revs of $8.85-9.65 bln vs. $8.73 bln Thomson Reuters consensus.

Comments »

Flash: FormFactor beats by $0.10, beats on revs (10.70 +0.78) Reports Q1 (Mar) loss of $0.32 per share, ex-items, $0.10 better than the Thomson Reuters consensus of ($0.42); revenues fell 8.0% year/year to $40.4 mln vs the $36.9 mln consensus.

Reports Q1 (Mar) loss of $0.32 per share, ex-items, $0.10 better than the Thomson Reuters consensus of ($0.42); revenues fell 8.0% year/year to $40.4 mln vs the $36.9 mln consensus.

Comments »

Flash: Broadcom prelim GAAP $0.40 vs GAAP $0.35 Thomson Reuters consensus; revs $1.82 bln vs $1.81 bln Thomson Reuters consensus

Broadcom sees Q2 revs $1.75-1.85 bln vs $1.90 bln Thomson Reuters consensus; GAAP product margin up ~50 bps QoQ

Broadcom beats GAAP ests by $0.05, reports revs in-line; guides Q2 revs below consensus  (40.41 +0.25)
Reports Q1 (Mar) earnings of $0.40 per share, $0.05 better than the Thomson Reuters consensus of $0.35; revenues rose 24.2% year/year to $1.82 bln vs the $1.81 bln consensus. Co issues downside guidance for Q2, sees Q2 revs of $1.75-1.85 bln vs. $1.9 bln Thomson Reuters consensus, with product gross margin up ~50 bps QoQ from 48.9%. non-GAAP operating margin of 22.6% vs. the 21.3% consensus; gross margin: 50.7% product gross margin: 48.9%. “In addition, momentum continues to build around our innovative solutions. Following a record year in 2010, we had record design wins in the first quarter, which speaks to the continued underlying strength of our integrated solutions for the Home, Hand and Infrastructure markets.”

Comments »

Flash: Panera Bread beats by $0.02, reports revs in-line; guides Q2 EPS above consensus; guides FY11 EPS above consensus

Reports Q1 (Mar) earnings of $1.09 per share, $0.02 better than the Thomson Reuters consensus of $1.07; revenues rose 15.9% year/year to $422.1 mln vs the $420.2 mln consensus. PNRA reports Q1 operating margin of 12.6% vs 12.2% Street Expectations. Co issues upside guidance for Q2, sees EPS of $1.15-1.17 vs. $1.10 Thomson Reuters consensus. Co is targeting a 0 to 50 bps y/y improvement in operating margins. Co issues upside guidance for FY11, sees EPS of $4.47-4.51 vs. $4.46 Thomson Reuters consensus. The Company is narrowing its fiscal 2011 target for Company-owned comparable bakery-cafe sales growth to 5.0% to 6.0% from 4.0% to 6.0%. This target assumes transaction growth of 2.5% to 3.5% and average check growth of approximately 2.5%. The increased average check growth target is primarily a result of an incremental 1.0% price increase the Company intends to take to offset increased inflation in the latter part of 2011. The incremental price increase and increased inflation are expected to offset each other at the operating margin line and have no impact on the Company’s earnings per diluted share target.

Comments »

Shares of Vertex Pharmaceuticals Soar on Expected FDA Approval for Hepatitis C Drug

“A drug like telaprevir does an amazing job clearing the virus, but there’s a small portion that is just intrinsically less responsive and it’s the job of the older drugs to clear up that mess that’s left behind,” said Dr. Cailla Graham, Vertex’s vice president for global medical affairs.

Full Article

Comments »

Today’s Winners and Losers

No. Ticker % Change
1 ECYT 31.89
2 REDF 24.13
3 IIVI 19.74
4 HSTM 19.11
5 VTRO 18.82
6 WTI 18.41
7 IGC 17.71
8 USAT 15.22
9 ONSM 14.75
10 KND 14.32
11 KUTV 14.00
12 UCTT 13.80
13 ARNA 12.60
14 SMOD 12.53
15 REFR 12.38
16 VRTX 12.09
17 PRGX 11.69
18 VICL 10.77
19 CRDN 10.60
20 CRS 10.56
21 IDN 10.42
22 MSPD 10.13
23 YRCW 10.05
24 DAL 10.00
25 GRA 9.96
—————————
No. Ticker % Change
1 GFRE -32.73
2 WIBC -18.38
3 HEI -18.18
4 LXK -14.73
5 VDSI -14.64
6 TZOO -12.91
7 ROSG -12.50
8 RCII -11.59
9 UIS -11.33
10 MNI -11.27
11 LFT -11.20
12 ININ -10.79
13 IMN -10.09
14 BXDD -10.03
15 ACPW -9.75
16 CTC -9.36
17 PLXT -9.29
18 UA -9.01
19 SCEI -8.99
20 CABL -8.26
21 APP -8.23
22 LWSN -8.12
23 BBH -8.11
24 AMCF -8.09
25 GPI -7.84

Comments »

Netflix Price Target Upped to $300 at Canaccord

Canaccord Genuity raises their NFLX tgt to $300 from $250. Netflix’s Q1/11 results exceeded forecasts, though Q2/11 guidance was mixed, with the company’s forecast revenue and subscriber growth offset by cost increases. Lack of subscriber growth in Canada was the only real surprise in the quarter, as churn and ARPU rose slightly following the price increase in January. Firm continue to believes that NFLX is in the sweet spot between declining physical competition and rising digital competition.

Comments »

Crack Spreads Edge Higher

Spreads are advancing to the tune of 1% this evening as crude goes lower.

Comments »

Japan Down More than 1% in Early Trade

Asian markets are off to a bad start, with the NIKKEI off by more than 1%. Additionally, all major commodities are under selling pressure.

Comments »